Sanuwave Health expects Q2 revenue of $8.5M-$9.5M
Sanuwave Health, Inc. expects Q2 2026 revenue of $8.5M-$9.5M, missing prior guidance from May 13. The company specializes in FDA-cleared directed energy systems for advanced wound care.
*this image is generated using AI for illustrative purposes only.
Sanuwave Health, Inc. (NASDAQ: SNWV) anticipates revenues for the second quarter of 2026 to fall between $8.5 million and $9.5 million. This revised outlook is below the guidance the company provided during its Q1 earnings call on May 13 of this year. The company specializes in FDA-cleared directed energy systems used in advanced wound care.
Financial Guidance
The company's revenue projection for the second quarter represents a decrease compared to earlier expectations. The table below outlines the current forecast against the context of the previous guidance.
| Metric | Q2 2026 Forecast |
|---|---|
| Revenue Range | $8.5 million - $9.5 million |
Context
Sanuwave Health attributes the revised revenue expectations to market conditions impacting sales performance. The company continues to focus on its advanced wound care solutions despite the short-term shortfall in revenue projections.
What specific market conditions are driving the decline in sales performance?
How will this revenue shortfall impact Sanuwave's full-year 2026 financial guidance?
What strategic initiatives is the company pursuing to counteract these short-term challenges?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
